Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 3 Pain, Postoperative 3 Neoplasms 3 Lung Neoplasms 3 Breast Neoplasms 3 Pancreatic Neoplasms 2 Pain 2 Colonic Neoplasms 2 Choledocholithiasis 2 Choledochal Cyst 2 Anxiety Disorders 2 Urinary Bladder Neoplasms 1 Terminal Cancer 1 Stomach Neoplasms 1 Solid Tumor 1 Skin Neoplasms 1 Sedation 1 Rectal Neoplasms 1 Postoperative Cognitive Complications 1 Polyps 1 Personal Satisfaction 1 Patient Satisfaction 1 Parasomnias 1 Pancreatitis 1 Pain, Intractable 1 Opioid-Related Disorders 1 Nausea 1 Mouth Neoplasms 1 Healthy 1 Glioma 1

Interventions

Bupivacaine 11 Ketamine 9 Ropivacaine 8 Acetaminophen 8 Morphine 7 Dexmedetomidine 7 Analgesics, Opioid 7 Lidocaine 6 Anesthesia, General 6 Saline Solution 5 Fentanyl 5 Anesthesia, Local 5 Acupuncture Therapy 5 parecoxib 4 Tramadol 4 Surveys and Questionnaires 4 Sodium Chloride 4 Ethanol 4 Analgesia, Epidural 4 Transcutaneous Electric Nerve Stimulation 3 Radiofrequency Ablation 3 Propofol 3 Oxycodone 3 Ketorolac 3 Control Groups 3 Anesthetics, Local 3 Therapeutics 2 Tea 2 Pregabalin 2 Magnesium Sulfate 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Agnosia × Midazolam × Clear all

NCT04597268 2023-01-10

Dexmedetomidine Versus Ketamine Versus Midazolam in Endoscopic Procedures

National Cancer Institute, Egypt

Phase NA Completed

Agnosia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡